Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Blood Transfusions: Everything You’ve Always Wanted to Know, But Didn’t Know Who to Ask Anne Eder, MD PhD Executive Medical Officer American Red Cross National Headquarters, Biomedical Services Washington, D.C. [email protected] Whole Blood Composed of: Liquid Cellular Plasma Platelets White Cells Neutrophils Lymphocytes Monocytes Red cells Buffy coat Hematocrit 38-45% Peripheral Blood Smear (CBC) Red Cells Hemoglobin Men: 16 + 2 g/dL Women: 14 + 2 g/dL White Cells 4,500 – 11,000 WBC/μL Platelets 150-400,000 platelets/μL 1 Red Cells (Erythrocytes) Carry oxygen to tissues Remove carbon dioxide from tissues Red Cells (“Packed RBC”) ~14 million units/year in U.S. Usually stored for 5-6 weeks at 4-10oC Red Cells (Erythrocytes) Transfusions are used to treat: Active bleeding (hemorrhage) Surgery Trauma Anemia Decreased RBC production Increased RBC destruction e.g. chemotherapy, bone marrow failure e.g. sickle cell anemia Expected response to transfusion: 1 RBC unit increases hemoglobin by 1.0 g/dL White Cells (leukocytes) Fight infections WBCs in RBC or platelets can cause transfusion reactions Febrile F b il nonhemolytic h l ti reactions ti Cytomegalovirus infection Alloimmunization Component preparation Engulf (phagocytize) bacteria to destroy them Generate antibodies Leukoreduction removes 99.9% WBC Irradiation inactivates WBC (lymphocytes); prevents TA-GVHD Rarely, WBC (neutrophil) transfusions to treat lifethreatening infections that don’t respond to standard treatment if marrow recovery is expected Typically 1 WBC per 1000 RBC 2 Platelets (thrombocytes) Important in clotting (stop bleeding) Secrete serotonin, which constricts blood vessels to slow bleeding Activate plasma proteins that form fibers, fibers which serve as a net to stop leaking red cells. Smaller than RBCs on a peripheral blood smear Can only be stored for 5 days with continuous gentle agitation at 20-24oC Typically 25 platelets per 1000 RBC Clotting Schematic Odyssey Magazine, 2010 Platelets Fibrin Endothelia Collagen Platelet Count and Bleeding Normal: 150-400,000/μl Gaydos et al NEJM 1962 Slichter and Harker1978 3 Petechial Hemorrhage Platelet therapy Single donor platelets (SDP) Whole Blood Platelets Apheresis yields 1-3 doses “Random “R d d donor platelets” l t l t ” (RDP) 4-6 products pooled for 1 dose Prophylactic use for low platelet count (thrombocytopenia) Therapeutic use to stop bleeding Expected response to transfusion (adults): • 1 RDP unit increases platelet count by • 6 RDP units (1 pool) or 1 SDP by 5,000-10,000 /µL 30,000 -60,000/µL Plasma Yellowish fluid, approx. 55% of whole blood donation Contains antibodies, clotting factors Used to treat bleeding patients with multiple clotting factor deficiency Source for further fractionation (separation) for factor concentrates (e.g., Factor VIII) Normal Plasma Expected response to transfusion (adults): • 1 plasma unit (~250 mL) - 1 unit/mL clotting factors; 400 mg fibrinogen; clinical response monitored by PT, PTT or bleeding 4 Blood Banking The process of collecting, manufacturing, testing, storing and distributing blood products for patient care Apheresis Donation (e.g., platelets) Every Donation is Tested ABO, Rh (blood type), Ab screen Hepatitis B HBsAg, Anti-HBc, Nucleic Acid Test Hepatitis C Antibodies, Nucleic Acid Test HIV 1/2 A tib di Antibodies, N Nucleic l i A Acid id T Testt HTLV I and HTLV-II Antibodies Syphilis Antibodies West Nile Virus Nucleic Acid Test T. cruzi (Chagas) Antibodies Bacteria Platelets only Optional CMV (Cytomegalovirus) Antibodies Sickle cell trait Screen for hemoglobin S 5 Transfusion-transmitted Infections Risk of a potentially infectious unit is calculated from mathematical models: Hepatitis B Hepatitis C HIV 1: 282 282,000 000 1: 1,149,000 1: 1,467,000 Lookback and investigations of suspected infections suggest risk is even lower (4 cases of transfusion-transmitted HIV have been documented since NAT introduced in 2004) Red Cell Compatibility: Blood type (RBCs) O A B AB A A Plasma antibodies Frequency (%) Compatible RBC transfusion Anti-A, anti-B A ti B Anti-B Anti-A None A 45% 41% 10% 4% O A or O B or O All (A, B, O or AB) A anti-B anti-B B B Group A ..if INCOMPATIBLE….Agglutination and Hemolysis Noninfectious Complications Febrile Allergic Anaphylaxis 1:100 1:100 1:20,000 to 50,000 V l Volume overload l d 1 100 tto 1 1:100 1:200 200 Septic (bacteria) 1:5,000,000 (red cells) 1:250,000 (apheresis platelets) TRALI 1:440,000 (red cells) 1:250,000 (plasma, male predominant) Hemolytic – acute (ABO incompatible) 1:12,000 to 1:38,000 Hemolytic - delayed 1:5400 to 1:62,000 6 Every transfusion should be monitored….. Symptoms Differential Diagnosis Acute hemolytic reaction (ABO incompatible) Febrile nonhemolytic reaction Sepsis (bacterial contamination of unit) Hives, itching Allergic transfusion reaction Difficulty breathing Fever Lower back pain Allergic transfusion reaction Transfusion-associate circulatory overload Transfusion-related acute lung injury Acute hemolysis (ABO incompatible) Delayed hemolysis Questions? Anne Eder, MD PhD Executive Medical Officer American Red Cross National Headquarters, Biomedical Services Washington, D.C. EderA @ usa.redcross.org 7